Acknowledgements
D:A:D participating cohorts: AHOD (Australia); Aquitaine (France); ATHENA (The Netherlands); BASS (Spain); CPCRA (USA); EuroSIDA (multinational); HivBivus (Sweden); ICONA (Italy); Nice (France); SHCS (Switzerland); and St. Pierre (Belgium).
D:A:D Steering Committee: names marked with 1, chair with 2.
Members of the D:A:D Steering Committee from the Oversight Committee: B. Powderly1, N. Shortman1, C. Moecklinghoff1, G. Reilly1 and X. Franquet1.
D:A:D central coordination: L. Ryom, C.A. Sabin1, D. Kamara, C. Smith, A. Phillips1, A. Mocroft, A. Bojesen, J. Nielsen, D. Raben and J.D. Lundgren2.
D:A:D data managers: R. Salbøl Brandt (coordinator), M. Rickenbach, I. Fanti, E. Krum, M. Hillebregt, S Geffard, A. Sundström, M. Delforge, E. Fontas, F. Torres, H. McManus, S. Wright and J. Kjær.
Verification of endpoints: A. Sjøl (CVD primary endpoint), P. Meidahl (oncology), J. Helweg-Larsen (hematology) and J. Schmidt Iversen (nephrology).
Kidney working group: L. Ryom, A. Mocroft, O. Kirk1, P. Reiss1, M. Ross, C.A. Fux, P. Morlat, O. Moranne, D.A. Kamara, C. Smith and J.D. Lundgren2.
Mortality working group: C. Smith, L. Ryom, A. Phillips1, R. Weber1, P. Morlat, C. Pradier1, P. Reiss1, N. Friis-Møller, J. Kowalska and J.D. Lundgren2.
Cancer working group: C. Sabin1, M. Law1, A. d’Arminio Monforte1, F. Dabis1, M. Bruyand, P. Reiss1, C. Smith, D.A. Kamara, M. Bower, G. Fätkenheuer, A. Donald, A. Grulich, L. Ryom and J.D. Lundgren2.
The members of the 11 cohorts are as follows:
1. AIDS Therapy Evaluation in the Netherlands (ATHENA) project, The Netherlands
Central coordination: P. Reiss1, S. Zaheri, M. Hillebregt and L. Gras.
Participating physicians: Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam: Prof. Dr. J.M. Prins3, Prof. Dr. T.W. Kuijpers, Dr. H.J. Scherpbier, Dr. J.T.M. van der Meer, Dr. F.W.M.N. Wit, Dr. M.H. Godfried, Prof. Dr. P. Reiss1,3, Prof. Dr. T. van der Poll, Dr. F.J.B. Nellen, Prof. Dr. J.M.A. Lange, Dr. S.E. Geerlings, Dr. M. van Vugt, Dr. D. Pajkrt, Drs. J.C. Bos, Drs. M. van der Valk, Drs. M.L. Grijsen, Dr. W.J. Wiersinga, Dr. A. Goorhuis and Dr. J.W.R. Hovius; Academisch Ziekenhuis Maastricht, Maastricht: Dr. S. Lowe3, Dr. A. Oude Lashof and Dr. D. Posthouwer; Catharina Ziekenhuis, Eindhoven: Drs. M.J.H. Pronk3 and Dr. H.S.M. Ammerlaan; Erasmus Medisch Centrum, Rotterdam: Dr. M.E. van der Ende3, Dr. T.E.M.S. de Vries-Sluijs, Dr. C.A.M. Schurink, Dr. J.L. Nouwen, Dr. A. Verbon, Drs. B.J.A. Rijnders, Dr. E.C.M. van Gorp and Drs. M. van der Feltz; Erasmus Medisch Centrum–Sophia, Rotterdam: Dr. G.J.A. Driessen and Dr. A.M.C. van Rossum; Flevoziekenhuis, Almere: Dr. J. Branger3; HagaZiekenhuis, Den Haag: Dr. E.F. Schippers3, Dr. C. van Nieuwkoop and Drs. E.P. van Elzakker; Isala Klinieken, Zwolle: Dr. P.H.P. Groeneveld3 and Drs. J.W. Bouwhuis; Kennemer Gasthuis, Haarlem: Drs. R. Soetekouw3 and Prof. Dr. R.W. ten Kate; Leids Universitair Medisch Centrum, Leiden: Dr. F.P. Kroon3, Prof. Dr. J.T. van Dissel, Dr. S.M. Arend, Dr. M.G.J. de Boer, Drs. H. Jolink, Dr. H.J.M. ter Vollaard and Drs. M.P. Bauer; Maasstadziekenhuis, Rotterdam: Dr. J.G. den Hollander3 and Dr. K. Pogany; Medisch Centrum Alkmaar, Alkmaar: Drs. G. van Twillert3, Drs. W. Kortmann3, Dr. J.W.T. Cohen Stuart and Dr. B.M.W. Diederen; Medisch Centrum Haaglanden, Den Haag: Dr. E.M.S. Leyten3 and Dr. L.B.S. Gelinck; Medisch Spectrum Twente, Enschede: Drs. G.J. Kootstra3 and Drs. C.E. Delsing; Onze Lieve Vrouwe Gasthuis, Amsterdam: Prof. Dr. K. Brinkman3, Dr. W.L. Blok, Dr. P.H.J. Frissen, Drs. W.E.M. Schouten and Drs. G.E.L. van den Berk; St. Elisabeth Ziekenhuis, Tilburg: Dr. M.E.E. van Kasteren3 and Dr. A.E. Brouwer; St. Lucas Andreas Ziekenhuis, Amsterdam: Dr. J. Veenstra3 and Dr. K.D. Lettinga; Slotervaartziekenhuis, Amsterdam: Dr. J.W. Mulder3, Drs. S.M.E. Vrouenraets and Dr. F.N. Lauw; Stichting Medisch Centrum Jan van Goyen, Amsterdam: Drs. A. van Eeden3 and Dr. D.W.M. Verhagen; Universitair Medisch Centrum Groningen, Groningen: Drs. H.G. Sprenger3, Drs. R. Doedens, Dr. E.H. Scholvinck, Dr. S. van Assen and Dr. W.F.W. Bierman; Universitair Medisch Centrum Sint Radboud, Nijmegen: Dr. P.P. Koopmans3, Dr. M. Keuter, Dr. A.J.A.M. van der Ven, Dr. H.J.M. ter Hofstede, Dr. A.S.M. Dofferhoff, Dr. A Warris and Dr. R. van Crevel; Universitair Medisch Centrum Utrecht, Utrecht: Prof. Dr. A.I.M. Hoepelman3, Dr. T. Mudrikova, Dr. M.M.E. Schneider, Dr. P.M. Ellerbroek, Dr. J.J. Oosterheert, Dr. J.E. Arends, Dr. M.W.M. Wassenberg and Dr. R.E. Barth; Vrije Universiteit Amsterdam, Amsterdam: Dr. M.A. van Agtmael3, Dr. R.M. Perenboom, Drs. F.A.P. Claessen, Dr. M. Bomers and Dr. E.J.G. Peters; Wilhelmina Kinderziekenhuis, Utrecht: Dr. S.P.M. Geelen, Dr. T.F.W. Wolfs and Dr. L.J. Bont; Ziekenhuis Rijnstate, Arnhem: Dr. C. Richter3, Dr. J.P. van der Berg and Dr. E.H. Gisolf; Admiraal De Ruyter Ziekenhuis, Vlissingen: Drs. M. van den Berge3 and Drs. A. Stegeman; Medisch Centrum Leeuwarden, Leeuwarden: Dr. M.G.A. van Vonderen3 and Drs. D.P.F. van Houte; Medisch Centrum Zuiderzee, Lelystad: Dr. S. Weijer3 and Dr. R. el Moussaoui; and St. Elisabeth Hospitaal, Willemstad, Curaçao: Dr. C. Winkel, Drs. F. Muskiet, Drs. Durand and Drs. R. Voigt. Site-coordinating physicians marked with 3.
2. Aquitaine Cohort, France
Principal investigator: Pr F. Dabis1.
Scientific committee: Prs F. Bonnet, F. Dabis1, M. Dupon, G. Chêne, D. Breilh, H. Fleury, D. Malvy, P. Mercié, I. Pellegrin, P. Morlat, D. Neau, JL. Pellegrin; Drs S. Bouchet, V. Gaborieau, D. Lacoste, S. Tchamgoué and R. Thiébaut.
Composition of the Groupe Epidémiologique Clinique du Sida en Aquitaine (GECSA): Prs G. Chêne, F. Dabis, R. Thiébaut; Drs M. Bruyand, S. Lawson-Ayayi and L. Wittkop (epidemiology and biostatistics).
Clinical and biological hospital units: Bordeaux University Hospital, Bordeaux: Pr P. Morlat (Pr F. Bonnet, Drs N. Bernard, M. Hessamfar, D. Lacoste, M.A. Vandenhende), Pr M. Dupon (Drs F.A. Dauchy, H. Dutronc), Pr M. Longy-Boursier (Pr P. Mercié, Drs P. Duffau, J. Roger Schmeltz), Pr D. Malvy (Drs T. Pistone, M.C. Receveur), Pr D. Neau (Drs C. Cazanave, A. Ochoa, M.O. Vareil), Pr J.L. Pellegrin (Pr J.F. Viallard, Drs C. Greib, E. Lazaro), Pr H. Fleury (Pr M.E. Lafon, Drs S. Reigadas, P. Trimoulet), Pr D. Breilh, Pr M. Molimard (Drs S. Bouchet, K. Titier), Pr J.F. Moreau (Dr I. Pellegrin), Drs F. Haramburu and G. Miremont-Salamé; Arcachon Hospital, Arcachon: Dr A. Dupont; Dax Hospital, Dax: Dr Y. Gerard (Drs L. Caunègre, K. André); Bayonne Hospital, Bayonne: Dr F. Bonnal (Drs S. Farbos, M.C. Gemain); Libourne Hospital, Libourne: Dr J. Ceccaldi (Dr S. Tchamgoué); Mont-de-Marsan Hospital, Mont-de-Marsan: Dr S. De Witte (Dr C. Courtault); Pau Hospital, Pau: Dr E. Monlun (Dr V. Gaborieau); Périgueux Hospital, Périgueux: Dr P. Lataste (Dr JP. Meraud); and Villeneuve-sur-Lot Hospital: Dr I. Chossat.
Permanent team: M.J. Blaizeau, M. Bruyand, V. Conte, M. Decoin, J. Delaune, S. Delveaux, F. Diarra, C. D’Ivernois, A. Frosch, S. Geffard, C. Hannapier, S. Lawson-Ayayi, E. Lenaud, O. Leleux, F. Le Marec, J. Leray, I. Louis, G. Palmer, A. Pougetoux, X. Sicard, D. Touchard and B. Uwamaliya-Nziyumvira.
3. Australian HIV Observational Database (AHOD), Australia
Central coordination: M. Law1, K. Petoumenos, H. McManus, S. Wright and C. Bendall (Sydney, New South Wales).
Participating physicians: R. Moore, S. Edwards, J. Hoy, K. Watson, N. Roth, J. Nicholson (Melbourne, Victoria); M. Bloch, T. Franic, D. Baker, R. Vale, A. Carr, D. Cooper (Sydney, New South Wales); J. Chuah, M. Ngieng (Gold Coast, Queensland); D. Nolan and J. Skett (Perth, Western Australia).
4. Barcelona Antiretroviral Surveillance Study (BASS), Spain
Central coordination: G. Calvo1, F. Torres and S. Mateu (Barcelona).
Participating physicians: P. Domingo, M.A. Sambeat, J. Gatell, E. Del Cacho, J. Cadafalch, M. Fuster (Barcelona); C. Codina, G. Sirera and A. Vaqué (Badalona).
5. The Brussels St. Pierre Cohort, Belgium
Coordination: S. De Wit1, N. Clumeck, M. Delforge and C. Necsoi.
Participating physicians: N. Clumeck, S. De Wit1, A.F. Gennotte, M. Gerard, K. Kabeya, D. Konopnicki, A. Libois, C. Martin, M.C. Payen, P. Semaille and Y. Van Laethem.
6. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA), USA
Central coordination: J. Neaton, G. Bartsch, W.M. El-Sadr1, E. Krum, G. Thompson and D. Wentworth.
Participating physicians: R. Luskin-Hawk (Chicago, IL); E. Telzak (Bronx, NY); W.M. El-Sadr (Harlem, NY); D.I. Abrams (San Francisco, CA); D. Cohn (Denver, CO); N. Markowitz (Detroit, MI); R. Arduino (Houston, TX); D. Mushatt (New Orleans, LA); G. Friedland (New Haven, CT); G. Perez (Newark, NJ); E. Tedaldi (Philadelphia, PA); E. Fisher (Richmond, VA); F. Gordin (Washington, DC); L.R. Crane (Detroit, MI); J. Sampson (Portland, OR); and J. Baxter (Camden, NJ).
7. EuroSIDA, multinational
Coordinating centre: J. Lundgren1,2, O. Kirk1, A. Mocroft, A. Cozzi-Lepri, D. Grint, D. Podlekareva, J. Kjær, L. Peters, J. Reekie, J. Kowalska, J. Tverland, A.H. Fischer and J. Nielsen.
Participating countries and physicians:
Argentina: (M. Losso), C. Elias, Hospital JM Ramos Mejia, Buenos Aires.
Austria: (N. Vetter), Pulmologisches Zentrum der Stadt Wien, Vienna; and R. Zangerle, Medical University Innsbruck, Innsbruck.
Belarus: (I. Karpov), A. Vassilenko, Belarus State Medical University, Minsk; V.M. Mitsura, Gomel State Medical University, Gomel; and O. Suetnov, Regional AIDS Centre, Svetlogorsk.
Belgium: (N. Clumeck), S. De Wit1 and M. Delforge, Saint-Pierre Hospital, Brussels; R. Colebunders, Institute of Tropical Medicine, Antwerp; and L. Vandekerckhove, University Ziekenhuis Gent, Gent.
Bosnia-Herzegovina: (V. Hadziosmanovic), Klinicki Centar Univerziteta Sarajevo, Sarajevo.
Bulgaria: (K. Kostov), Infectious Diseases Hospital, Sofia.
Croatia: (J. Begovac), University Hospital of Infectious Diseases, Zagreb.
Czech Republic: (L. Machala), D. Jilich, Faculty Hospital Bulovka, Prague; and D. Sedlacek, Charles University Hospital, Plzen.
Denmark: (J. Nielsen), G. Kronborg, T. Benfield and M. Larsen, Hvidovre Hospital, Copenhagen; J. Gerstoft, T. Katzenstein, A.B.E. Hansen and P. Skinhøj, Rigshospitalet, Copenhagen; C. Pedersen, Odense University Hospital, Odense; and L. Ostergaard, Skejby Hospital, Aarhus.
Estonia: (K. Zilmer), West-Tallinn Central Hospital, xTallinn; and J. Smidt, Nakkusosakond Siseklinik, Kohtla-Järve.
Finland: (M. Ristola), Helsinki University Central Hospital, Helsinki.
France: (C. Katlama), Hôpital de la Pitié-Salpétière, Paris; J.P. Viard, Hôpital Necker-Enfants Malades, Paris; P.M. Girard, Hospital Saint-Antoine, Paris; J.M. Livrozet, Hôpital Edouard Herriot, Lyon; P. Vanhems, University Claude Bernard, Lyon; C. Pradier, Hôpital de l’Archet, Nice; and F. Dabis1 and D. Neau, Unité INSERM, Bordeaux.
Germany: (J. Rockstroh), Universitäts Klinik Bonn; R. Schmidt, Medizinische Hochschule Hannover; J. van Lunzen and O. Degen, University Medical Center Hamburg-Eppendorf, Infectious Diseases Unit, Hamburg; H.J. Stellbrink, IPM Study Center, Hamburg; S. Staszewski, J.W. Goethe University Hospital, Frankfurt; M. Bickel, Medizinische Poliklinik, Munich; and G. Fätkenheuer, Universität Köln, Cologne.
Greece: (J. Kosmidis), P. Gargalianos, G. Xylomenos and J. Perdios, Athens General Hospital, Athens; G. Panos, A. Filandras and E. Karabatsaki, 1st IKA Hospital, Athens; and H. Sambatakou, Ippokration Genereal Hospital, Athens.
Hungary: (D. Banhegyi), Szent Lásló Hospital, Budapest.
Ireland: (F. Mulcahy), St. James’s Hospital, Dublin.
Israel: (I. Yust), D. Turner and M. Burke, Ichilov Hospital, Tel Aviv; S. Pollack and G. Hassoun, Rambam Medical Center, Haifa; and S. Maayan, Hadassah University Hospital, Jerusalem.
Italy: (S. Vella), Istituto Superiore di Sanità, Rome; R. Esposito, I. Mazeu and C. Mussini, Università Modena, Modena; C. Arici, Ospedale Riuniti, Bergamo; R. Pristera, Ospedale Generale Regionale, Bolzano; F. Mazzotta, A. Gabbuti, Ospedale Santa Maria Annunziata, Firenze; V. Vullo and M. Lichtner, University di Roma la Sapienza, Rome; A. Chirianni, E. Montesarchio and M. Gargiulo, Presidio Ospedaliero AD Cotugno, Monaldi Hospital, Napoli; G. Antonucci, A. Testa, P. Narciso, C. Vlassi and M. Zaccarelli, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome; A. Lazzarin, A. Castagna and N. Gianotti, Ospedale San Raffaele, Milan; M. Galli and A. Ridolfo, Ospedale Luigi Sacco, Milan; and A. d’Arminio Monforte, Istituto Di Clinica Malattie Infettive e Tropicale, Milan.
Latvia: (B. Rozentale), I. Zeltina, Infectology Centre of Latvia, Riga.
Lithuania: (S. Chaplinskas), Lithuanian AIDS Centre, Vilnius.
Luxembourg: (R. Hemmer), T. Staub, Centre Hospitalier, Luxembourg.
Netherlands: (P. Reiss1), Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam.
Norway: (V. Ormaasen), A. Maeland and J. Bruun, Ullevål Hospital, Oslo.
Poland: (B. Knysz), J. Gasiorowski, Medical University, Wroclaw; A. Horban and E. Bakowska, Centrum Diagnostyki i Terapii AIDS, Warsaw; A. Grzeszczuk and R. Flisiak, Medical University, Bialystok; A. Boron-Kaczmarska, M. Pynka and M. Parczewski, Medical University, Szczecin; M. Beniowski and E. Mularska, Osrodek Diagnostyki i Terapii AIDS, Chorzow; H. Trocha, Medical University, Gdansk; and E. Jablonowska, E. Malolepsza and K. Wojcik, Wojewodzki Szpital Specjalistyczny, Lodz.
Portugal: (F. Antunes), M. Doroana and L. Caldeira, Hospital Santa Maria, Lisbon; K. Mansinho, Hospital de Egas Moniz, Lisbon; and F. Maltez, Hospital Curry Cabral, Lisbon.
Romania: (D. Duiculescu), Spitalul Clinic de Boli Infectioase si Tropicale “Dr. Victor Babes”, Bucuresti.
Russia: (A. Rakhmanova), Medical Academy Botkin Hospital, St. Petersburg; N. Zakharova, St. Petersburg AIDS Centre, St. Peterburg; and S. Buzunova, Novgorod Centre for AIDS, Novgorod.
Serbia: (D. Jevtovic), Institute for Infectious and Tropical Diseases, Belgrade.
Slovakia: (M. Mokráš), D. Staneková, Dérer Hospital, Bratislava.
Slovenia: (J. Tomazic), University Clinical Centre Ljubljana, Ljubljana.
Spain: (J. González-Lahoz), V. Soriano, P. Labarga and J. Medrano, Hospital Carlos III, Madrid; S. Moreno and J.M. Rodriguez, Hospital Ramon y Cajal, Madrid; B. Clotet, A. Jou, R. Paredes, C. Tural, J. Puig and I. Bravo, Hospital Germans Trias i Pujol, Badalona; J.M. Gatell and J.M. Miró, Hospital Clinic i Provincial, Barcelona; and P. Domingo, M. Gutierrez, G. Mateo and M.A. Sambeat, Hospital Sant Pau, Barcelona.
Sweden: (A. Karlsson), Venhaelsan-Sodersjukhuset, Stockholm; and L. Flamholc, Malmö University Hospital, Malmö.
Switzerland: (B. Ledergerber), R. Weber1, University Hospital, Zürich; P. Francioli and M. Cavassini, Centre Hospitalier Universitaire Vaudois, Lausanne; B. Hirschel and E. Boffi, Hospital Cantonal Universitaire de Geneve, Geneva; H. Furrer, Inselspital Bern, Bern; and M. Battegay and L. Elzi, University Hospital Basel, Basel.
Ukraine: (E. Kravchenko), N. Chentsova, Kiev Centre for AIDS, Kiev; V. Frolov and G. Kutsyna, Luhansk State Medical University; Luhansk; S. Servitskiy, Odessa Region AIDS Center, Odessa; and M. Krasnov, Kharkov State Medical University, Kharkov.
United Kingdom: (S. Barton), John Hunter Clinic, Chelsea and Westminster Hospital, London; A.M. Johnson and D. Mercey, Royal Free and University College London Medical School, London (University College Campus); A. Phillips, M.A. Johnson and A. Mocroft, Royal Free and University College London Medical School, London (Royal Free Campus); M. Murphy, Medical College of St. Bartholomew’s Hospital, London; J. Weber and G. Scullard, Faculty of Medicine at Imperial College London, St. Mary’s Hospital, London; M. Fisher, Royal Sussex County Hospital, Brighton; and C. Leen, Western General Hospital, Edinburgh.
8. HivBivus, Sweden
Central coordination: L. Morfeldt1, G. Thulin and A. Sundström.
Participating physicians: B. Åkerlund (Huddinge); K. Koppel, A. Karlsson (Stockholm); L. Flamholc and C. Håkangård (Malmö).
9. The ICONA Foundation, Italy
Board of directors: M. Moroni (chair), G. Angarano, A. Antinori, O. Armignacco, A. d’Arminio Monforte1, F. Castelli, R. Cauda, G. Di Perri, M. Galli, R. Iardino, G. Ippolito, A. Lazzarin, C.F. Perno, F. von Schloesser and P. Viale.
Scientific secretary: A d’Arminio Monforte1, A. Antinori, A. Castagna, F. Ceccherini-Silberstein, A. Cozzi-Lepri, E. Girardi, S. Lo Caputo, C. Mussini and M. Puoti.
ICONA Steering Committee: M. Andreoni, A. Ammassari, A. Antinori, A. d’Arminio Monforte, C. Balotta, P. Bonfanti, S. Bonora, M. Borderi, R. Capobianchi, A. Castagna, F. Ceccherini-Silberstein, A. Cingolani, P. Cinque, A. Cozzi-Lepri, A. De Luca, A. Di Biagio, E. Girardi, N. Gianotti, A. Gori, G. Guaraldi, G. Lapadula, M. Lichtner, S. Lo Caputo, G. Madeddu, F. Maggiolo, G. Marchetti, S. Marcotullio, L. Monno, C. Mussini, M. Puoti, E. Quiros Roldan and S. Rusconi.
Statistical and monitoring team: A.Cozzi-Lepri, P. Cicconi, I. Fanti, T. Formenti, L. Galli and P. Lorenzini.
Participating physicians: A. Giacometti, A. Costantini (Ancona); G. Angarano, L. Monno, C. Santoro (Bari); F. Maggiolo, C. Suardi (Bergamo); P. Viale, E. Vanino, G. Verucchi (Bologna); F. Castelli, E. Quiros Roldan, C. Minardi (Brescia); T. Quirino, C. Abeli (Busto Arsizio); P.E. Manconi, P. Piano (Cagliari); J. Vecchiet, K. Falasca (Chieti); L. Sighinolfi, D. Segala (Ferrara); F. Mazzotta, S. Lo Caputo (Firenze); G. Cassola, G. Viscoli, A. Alessandrini, R. Piscopo, G. Mazzarello (Genova); C. Mastroianni, V. Belvisi (Latina); P. Bonfanti, I. Caramma (Lecco); A.P. Castelli (Macerata); M. Galli, A. Lazzarin, G. Rizzardini, M. Puoti, A. d’Arminio Monforte, A.L. Ridolfo, R. Piolini, A. Castagna, S. Salpietro, L. Carenzi, M.C. Moioli, P. Cicconi, G. Marchetti (Milano); C. Mussini, C. Puzzolante (Modena); A. Gori, G. Lapadula (Monza); N. Abrescia, A. Chirianni, M.G. Guida, M. Onofrio (Napoli); F. Baldelli, D. Francisci (Perugia); G. Parruti, T. Ursini (Pescara); G. Magnani, M.A. Ursitti (Reggio Emilia); R. Cauda, M. Andreoni, A. Antinori, V. Vullo, A. Cingolani, A. d’Avino, A. Ammassari, L. Gallo, E. Nicastri, R. Acinapura, M. Capozzi, R. Libertone, G. Tebano (Roma); A. Cattelan (Rovigo); M.S. Mura, G. Madeddu (Sassari); P. Caramello, G. Di Perri, G.C. Orofino, S. Bonora, M. Sciandra (Torino); G. Pellizzer and V. Manfrin (Vicenza).
10. Nice HIV Cohort, France
Central coordination: C. Pradier1, E. Fontas and C. Caissotti.
Participating physicians: P. Dellamonica, E. Bernard, E. Cua, F. De Salvador-Guillouet, J. Durant, S. Ferrando, V. Mondain-Miton, A. Naqvi, I. Perbost, B. Prouvost-Keller, S. Pillet, P. Pugliese, V. Rahelinirina and P.M. Roger.
Clinical research assistant: K. Dollet.
11. Swiss HIV Cohort Study (SHCS), Switzerland
Participating physicians: V. Aubert, M. Battegay, E. Bernasconi, J. Böni, H.C. Bucher, C. Burton-Jeangros, A. Calmy, M. Cavassini, G. Dollenmaier, M. Egger, L. Elzi, J. Fehr, J. Fellay, H. Furrer (Chairman of the Clinical and Laboratory Committee), C.A. Fux, M. Gorgievski, H. Günthard (President of the SHCS), D. Haerry (Deputy of “Positive Council”), B. Hasse, H.H. Hirsch, M. Hoffmann, I. Hösli, C. Kahlert, L. Kaiser, O. Keiser, T. Klimkait, R. Kouyos, H. Kovari, B. Ledergerber, G. Martinetti, B. Martinez de Tejada, K. Metzner, N. Müller, D. Nadal, D. Nicca, G. Pantaleo, A. Rauch (Chairman of the Scientific Board), S. Regenass, M. Rickenbach (Head of Data Center), C. Rudin (Chairman of the Mother and Child Substudy), F. Schöni-Affolter, P. Schmid, J. Schüpbach, R. Speck, P. Tarr, A. Telenti, A. Trkola, P. Vernazza, R. Weber1 and S. Yerly.
Source of funding
This work was supported by the Highly Active Antiretroviral Therapy Oversight Committee (HAART-OC), a collaborative committee with representation from academic institutions, the European Medicines Agency (EMA), the United States Food and Drug Administration (FDA), the patient community, and all pharmaceutical companies with licensed anti-HIV drugs in the European Union: AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, Merck, Pfizer, F. Hoffman-La Roche and Janssen Pharmaceuticals.
Supported by a grant [grant number CURE/97-46486] from the Health Insurance Funds Council, Amstelveen, The Netherlands, to the AIDS Therapy Evaluation in the Netherlands (ATHENA) project; by a grant from the Agence Nationale de Recherches sur le sida [grant number Action Coordonnée no.7, Cohortes], to the Aquitaine Cohort; The Australian HIV Observational Database (AHOD) is funded as part of the Asia Pacific HIV Observational Database, a program of The American Foundation for AIDS Research, amfAR, and is supported in part by a grant from the United States National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) [grant number U01-AI069907], and by unconditional grants from Merck, Gilead Sciences, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Pfizer, GlaxoSmithKline and Janssen Pharmaceuticals. The Kirby Institute is funded by The Australian Government Department of Health, and is affiliated with the Faculty of Medicine, The University of New South Wales (UNSW). By grants from the Fondo de Investigación Sanitaria [grant number FIS 99/0887] and Fundación para la Investigación y la Prevención del Sida en Espanã [grant number FIPSE 3171/00], to the Barcelona Antiretroviral Surveillance Study (BASS); by the National Institute of Allergy and Infectious Diseases, National Institutes of Health [grant numbers 5U01AI042170-10, 5U01AI046362-03], to the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA); by grants from the BIOMED 1 [grant number CT94-1637] and BIOMED 2 [grant number CT97-2713] programs and the fifth framework program [grant number QLK2-2000-00773] of the European Commission, and grants from Bristol-Myers Squibb, GlaxoSmithKline, Boehringer Ingelheim and Roche, to the EuroSIDA study; by unrestricted educational grants of AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Pfizer and Janssen Pharmaceuticals to the Italian Cohort Naive to Antiretrovirals (The ICONA Foundation); and by a grant from the Swiss National Science Foundation, to the Swiss HIV Cohort Study (SHCS).
The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above.